ATAIBECKLEY INC (ATAI) Stock Price, Forecast & Analysis
NASDAQ:ATAI • US04650F1012
ATAI Key Statistics, Chart & Performance
The current stock price of ATAI is 3.57 USD. In the past month the price decreased by -3.77%. In the past year, price increased by 55.22%.
ATAI Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to ATAI. When comparing the yearly performance of all stocks, ATAI is one of the better performing stocks in the market, outperforming 81.36% of all stocks.
ATAI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ATAI. No worries on liquidiy or solvency for ATAI as it has an excellent financial health rating, but there are worries on the profitability.
ATAI Financial Highlights
Over the last trailing twelve months ATAI reported a non-GAAP Earnings per Share(EPS) of -0.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -62.24% | ||
| ROE | -93.44% | ||
| Debt/Equity | 0 |
ATAI Forecast & Estimates
19 analysts have analysed ATAI and the average price target is 12.7 USD. This implies a price increase of 255.84% is expected in the next year compared to the current price of 3.57.
For the next year, analysts expect an EPS growth of 30.12% and a revenue growth 475.51% for ATAI
ATAI Ownership
ATAI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 30.99 | 983.195B | ||
| JNJ | JOHNSON & JOHNSON | 20.9 | 586.544B | ||
| MRK | MERCK & CO. INC. | 22.44 | 301.342B | ||
| PFE | PFIZER INC | 9.18 | 156.812B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.98 | 123.651B | ||
| ZTS | ZOETIS INC | 18.44 | 55.813B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.71 | 26.086B | ||
| VTRS | VIATRIS INC | 6.23 | 18.163B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 24.04 | 12.486B | ||
| AXSM | AXSOME THERAPEUTICS INC | 221.27 | 9.135B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ATAI
Company Profile
The company is headquartered in New York City, New York and currently employs 54 full-time employees. The company went IPO on 2021-06-18.
Company Info
ATAIBECKLEY INC
c/o atai Life Sciences US, Inc., c/o Industrious NYC, 250 West 34th Street
New York City NEW YORK 100022 US
CEO: Florian Brand
Employees: 54
Phone: 13026587581
ATAIBECKLEY INC / ATAI FAQ
What does ATAI do?
The company is headquartered in New York City, New York and currently employs 54 full-time employees. The company went IPO on 2021-06-18.
Can you provide the latest stock price for ATAIBECKLEY INC?
The current stock price of ATAI is 3.57 USD. The price decreased by -0.28% in the last trading session.
Does ATAI stock pay dividends?
ATAI does not pay a dividend.
What is the ChartMill rating of ATAIBECKLEY INC stock?
ATAI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Is ATAIBECKLEY INC (ATAI) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ATAI.
How many employees does ATAIBECKLEY INC have?
ATAIBECKLEY INC (ATAI) currently has 54 employees.
What is the outstanding short interest for ATAIBECKLEY INC?
The outstanding short interest for ATAIBECKLEY INC (ATAI) is 4.19% of its float.